According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.
Four gurus are invested in Acadia Pharmaceuticals Inc. (ACAD, Financial).
The biopharmaceutical company has a market cap of $3.99 billion.
The stock is trading with a price-book (P/B) ratio of 10.42. The current stock price of $32.13 is 22.01% below its 52-week high and 28.21% above its 52-week low. Over the past 10 years, it has returned a gain of 201%.
The company’s largest shareholder among the gurus is Paul Singer (Trades, Portfolio) with 0.86% of outstanding shares, followed by Steven Cohen (Trades, Portfolio) with 0.58%, Joel Greenblatt (Trades, Portfolio) with 0.03% and George Soros (Trades, Portfolio) with 0.01%.
Portola Pharmaceuticals Inc. (PTLA, Financial) is held by four gurus.
The biotechnology company has a market cap of $3.54 billion.
The stock is trading with a price-book ratio of 7.36. The current stock price of $54.23 is 19.18% below its 52-week high and 119.55% above its 52-week low. Over the past decade, it has returned a gain of 132%.
Jim Simons (Trades, Portfolio) is the company's largest guru shareholder owith 0.81% of outstanding shares, followed by Ken Fisher (Trades, Portfolio) with 0.15%, Leon Cooperman (Trades, Portfolio) with 0.08% and Paul Tudor Jones (Trades, Portfolio) with 0.05%.
Incyte Corp. (INCY, Financial) is held by 14 gurus.Â
The biopharmaceutical company has a market cap of $20.16 billion. Its revenue has grown 48% annually over the past 10 years.
The stock is trading with a price-book ratio of 11.45. The current stock price of $95.51 is 38.45% below its 52-week high and 6.14% above its 52-week low. Over the past 10 years, it has returned a gain of 717%.
With 4.49% of outstanding shares, the Vanguard Health Care Fund (Trades, Portfolio) is the company's largest guru shareholder, followed by Frank Sands (Trades, Portfolio) with 3.59%, Manning & Napier Advisors Inc. with 0.51% and Cohen with 0.08%.
Seventeen gurus have positions in Celgene Corp. (CELG, Financial).
The biotech company has a market cap of $81.4 billion. Its revenue has grown 27.40% annually over the past decade.
The stock is trading with a price-book ratio of 11.76. The current stock price of $104.39 is 29.07% below its 52-week high and 10.41% above its 52-week low. Over the past decade, it has returned a gain of 287%.
Spiros Segalas (Trades, Portfolio) is the company's largest shareholder among the gurus with 0.41% of outstanding shares, followed by Pioneer Investments (Trades, Portfolio) with 0.32%, David Rolfe (Trades, Portfolio) with 0.09% and Simons with 0.05%.
Exelixis Inc. (EXEL, Financial) is held by six gurus.
The biotech company has a market cap of $8.99 billion. Its revenue has declined by 18.10% over the past 10 years.
The stock is trading with a price-book ratio of 38.93. The current stock price of $30.27 is 6.28% below its 52-week high and 82.18% above its 52-week low. Over the past 10 years, it has returned a gain of 318%.
The company’s largest guru shareholder is Simons with 1.28% of outstanding shares, followed by Greenblatt with 0.29% and Cohen with 0.08%.
Disclosure: I do not own any stocks mentioned in this article.
Also check out:
